問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-0518 023-02

2007-12-25 - 2009-09-30

Phase III

Terminated9

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator YU-HUI LIN Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 李欣純 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hsi-Hsun Lin Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Wang-Huei Sheng Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Jih-Jin Tsai Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王永衛 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 廖學聰 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王甯祺 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 蔡宏津 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    45 participants

  • Global

    5500 participants